Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mari Iida

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Journal of Toxicologic Pathology|October 11, 2021
Contribution of toxicologic pathologists for the safety of human health in biomedical research-past, present, and future of the JSTPMakoto Enomoto, Hijiri Iwata, Mari Iida
The Oncologist|July 8, 2009
The role of Src in solid tumorsDeric L Wheeler, Mari Iida, Emily F Dunn
Cancer Biology & Therapy|February 5, 2011
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximabToni M Brand, Mari Iida, Deric L Wheeler
Discovery Medicine|December 1, 2011
The nuclear epidermal growth factor receptor signaling network and its role in cancerToni M Brand, Mari Iida, Chunrong Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2010
Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinomaChunrong Li, Mari Iida, Emily F Dunn, et al.
Toxicology and Applied Pharmacology|July 25, 2003
Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 miceColleen H Anna, Mari Iida, Robert C Sills, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 30, 2007
The putative tumor suppressor Tsc-22 is downregulated early in chemically induced hepatocarcinogenesis and may be a suppressor of Gadd45bMari Iida, Colleen H Anna, Nicole D Gaskin, et al.
Plos One|August 17, 2013
Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3Toni M Brand, Mari Iida, Neha Luthar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2018
Corrigendum to: "Nuclear EGFR as a molecular target in cancer" [Radiother Oncol 108 (2013) 370-77]Toni M Brand, Mari Iida, Neha Luthar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2013
Nuclear EGFR as a molecular target in cancerToni M Brand, Mari Iida, Neha Luthar, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Journal of Toxicologic Pathology|October 11, 2021
Contribution of toxicologic pathologists for the safety of human health in biomedical research-past, present, and future of the JSTPMakoto Enomoto, Hijiri Iwata, Mari Iida
The Oncologist|July 8, 2009
The role of Src in solid tumorsDeric L Wheeler, Mari Iida, Emily F Dunn
Cancer Biology & Therapy|February 5, 2011
Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximabToni M Brand, Mari Iida, Deric L Wheeler
Discovery Medicine|December 1, 2011
The nuclear epidermal growth factor receptor signaling network and its role in cancerToni M Brand, Mari Iida, Chunrong Li, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2010
Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinomaChunrong Li, Mari Iida, Emily F Dunn, et al.
Toxicology and Applied Pharmacology|July 25, 2003
Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 miceColleen H Anna, Mari Iida, Robert C Sills, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 30, 2007
The putative tumor suppressor Tsc-22 is downregulated early in chemically induced hepatocarcinogenesis and may be a suppressor of Gadd45bMari Iida, Colleen H Anna, Nicole D Gaskin, et al.
Plos One|August 17, 2013
Mapping C-terminal transactivation domains of the nuclear HER family receptor tyrosine kinase HER3Toni M Brand, Mari Iida, Neha Luthar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 17, 2018
Corrigendum to: "Nuclear EGFR as a molecular target in cancer" [Radiother Oncol 108 (2013) 370-77]Toni M Brand, Mari Iida, Neha Luthar, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 9, 2013
Nuclear EGFR as a molecular target in cancerToni M Brand, Mari Iida, Neha Luthar, et al.
Pageof 6